Type 2 Diabetes

Adherence to type 2 diabetes medications did not significantly change from 2017 to 2019, and forgetfulness was the most common reason given for not taking medication as recommended, according to study findings.

Diabetic kidney disease is the leading cause of end-stage renal disease in the U.S., and 50% of adults initiating renal replacement therapy have diabetes, according to the CDC.

An analysis of data showed patients with chronic kidney disease and type 2 diabetes who were or were not prescribed mineralocorticoid receptor antagonists saw reductions in major adverse kidney outcomes after taking dapagliflozin.

Nearly 5% of adults aged 30 years or older diagnosed with type 2 diabetes between 2004 and 2018 in Scotland went on to achieve type 2 diabetes remission for at least 1 year, according to study findings published in PLOS Medicine.

Women with irregular menses are 20% more likely to develop cardiovascular disease and 17% more likely to develop type 2 diabetes over 20 years compared with women with regular menstrual cycles, according to an Australian database analysis.

People with type 2 diabetes and a hearing or vision impairment have an elevated risk for myocardial infarction, stroke and all-cause mortality, according to study findings published in the Journal of Diabetes Investigation.

The U.S. Preventive Services Task Force issued draft guidance today that states there is insufficient evidence to make a recommendation for or against prediabetes and type 2 diabetes screening in asymptomatic children and adolescents.

The risk for cardiovascular events is higher for adults with type 2 diabetes who have chronic kidney disease or other risk factors, even without the presence of cardiovascular disease, according to data published in Diabetic Medicine.

NEW ORLEANS — In patients with obesity and type 2 diabetes, bariatric surgery was found to be associated with fewer cases of diabetic retinopathy, according to a presenter at the American Academy of Ophthalmology meeting.

A low carbohydrate intervention targeting type 2 diabetes reversal and prediabetes regression may be an effective treatment method for nonalcoholic fatty liver disease, according to a speaker at The Liver Meeting Digital Experience.